(redirected from influenza A virus)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to influenza A virus: Influenza B virus
See: disease
References in periodicals archive ?
Patent 6,196,175 (issued January 2, 2001) for "Preparation and use of recombinant influenza A virus M2 construct vaccine" and U.
In addition, 3,401 fecal samples of wild birds were collected; all were negative for influenza A virus.
This mechanism could be a new marker for scientists to examine when attempting to predict the potential for a newly emergent influenza A virus to cause a pandemic.
The treatment's efficacy is questionable, and it is for this reason that eFoodSafety believes testing of its Citroxin product on the Influenza A virus could easily transpose test results to the Bird Flu virus and allow for a more rapid acceptance of product domestically.
Additional information regarding influenza viruses, influenza surveillance, influenza vaccines, influenza antiviral medications, and novel influenza A virus infections in humans is available at http://www.
Phylogenetic analyses showed maintenance of influenza A virus H7 subtypes in wild birds in eastern Asia since 1999 (clade A) (Figure 1, panel A).
The segmented genome allows viruses from different species to mix and create a new Influenza A virus if viruses from two different species infect the same person or animal.
The study, "Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers," was published in the peer-reviewed journal Antimicrobial Agents and Chemotherapy and is currently available online at http://aac.
Vortex Corporation, a global innovator of chemical-free water purification products for consumer and commercial use, today announced that its patented technology - currently funded by the Department of Homeland Security - effectively destroys the Avian Influenza A virus (commonly known as Bird Flu) in water.
section]) The CDC influenza surveillance system collects information in five categories from eight data sources: 1) viral surveillance (World Health Organization collaborating laboratories, the National Respiratory and Enteric Virus Surveillance System, and novel influenza A virus case reporting); 2) outpatient illness surveillance (U.
DNA transfection system for generation of influenza A virus from eight plasmids.
The first presentation, titled "Inhibition of Several Subtypes of Influenza A Virus with Antisense Morpholino Oligomers," was presented by AVI collaborators from Oregon State University and included data from collaborators at the Massachusetts Institute of Technology; the Public Health Agency of Canada in Winnipeg; and Mahidol University in Bangkok, Thailand.